human placental derived stem cells Report issue

Cell therapy Experimental
AACT

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

human placenta-derived cells | human placental derived stem cells | placenta derived mesenchymal stem cell | placental matrix-derived mesenchymal stem cells | plx-r18

Organizations (18)

Research & Development (18)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (33)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (33)


 

Acute Febrile Encephalopathy (Phase 2)

Adrenoleukodystrophy (Phase 1)

Anemia, Aplastic (Phase 1)

Anemia, Diamond-Blackfan (Phase 1)

Crohn Disease (Phase 2)

Diabetic Foot (Phase 2)

Erectile Dysfunction (Phase 1)

Fucosidosis (Phase 1)

Gaucher Disease (Phase 1)

Hematopoietic Stem Cell Transplantation (Phase 1)

Hepatitis B, Chronic (Phase 1/Phase 2)

Infarction, Middle Cerebral Artery (Phase 2)

Infarction, Posterior Cerebral Artery (Phase 2)

Intestinal Neoplasms (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Leukodystrophy, Globoid Cell (Phase 1)

Leukodystrophy, Metachromatic (Phase 1)

Meningomyelocele (Phase 1/Phase 2)

Mucopolysaccharidosis I (Phase 1)

Mucopolysaccharidosis VI (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Neuronal Ceroid-Lipofuscinoses (Phase 1)

Niemann-Pick Diseases (Phase 1)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 1/Phase 2)

Penile Induration (Phase 1)

Peripheral Arterial Disease (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Radiation Oncology (Phase 1)

Spinal Cord Compression (Phase 2)

Stem Cells (Phase 2)

Stroke (Phase 2)

Wolman Disease (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 23
  • # of Trial Organizations: 18

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue